NBOH-2C-CN Uses, Dosage, Side Effects and more
25CN-NBOH (NBOH-2C-CN) is a newly developed selective 5-HT2A agonist. It has been tested with regard to the head-twitch-response (HTR) model of 5-HT2A activity and effects on locomotion . It was discovered in 2014 at the University of Copenhagen.
| Attribute | Details |
|---|---|
| Trade Name | NBOH-2C-CN |
| Generic | N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine |
| N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine Other Names | 25CN-NBOH, NBOH-2C-CN |
| Type | |
| Formula | C18H20N2O3 |
| Weight | Average: 312.369 Monoisotopic: 312.147392512 |
| Groups | Experimental |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
How NBOH-2C-CN works
25CN-NBOH is one of the most selective agonist ligands for the 5-HT2A receptor discovered. It has a pKi of 8.88 at the human 5-HT2A receptor and is 100x more selective for 5-HT2A over 5-HT2C, and 46x more selective for 5-HT2A over 5-HT2B .
Innovators Monograph
Search Medicines